Our Facilities

Purpose built to deliver the purest proteins

AROTEC Diagnostics operates from a state-of-the-art facility in Wellington, New Zealand, purpose-built to deliver world-class autoimmune diagnostic reagents.

Equipped with advanced chromatographic and protein purification technologies, our facility consistently achieves large volume outputs of antigens, meeting the demands of customers worldwide.

Situated in a thriving scientific hub, our Wellington location provides access to exceptional talent, enabling our team to fully leverage cutting-edge equipment.

To efficiently serve our global customer base, distribution centers have been established in the USA and Europe. These hubs enable swift and reliable delivery, ensuring seamless access to our high-purity products.

Customers worldwide can rely on us for consistent, timely, and dependable support.

Our facilities are backed by extensive calibration and maintenance programs, 24/7 remote monitoring of critical equipment, and robust offsite backups. These measures ensure operational excellence and continuity at every stage, reflecting our unwavering commitment to serving our customers.

Combined with ISO 9001:2015-certified quality systems, this integration of expertise and technology ensures we uphold the highest standards across all aspects of our operations.

Have a look around

How we guarantee our quality standard

Extensive calibration

All equipment undergoes rigorous calibration and maintenance, ensuring traceability, reliability, and seamless production processes.

24/7 remote monitoring

Our critical equipment and freezers are remotely monitored 24/7, ensuring temperature-sensitive products are consistently maintained at optimal conditions.

Offsite
back-ups

Robust offsite backup systems are maintained, ensuring secure and reliable data preservation to safeguard production continuity and operational efficiency.

ISO certified

Operating under ISO 9001:2015 standards, demonstrates our commitment to the highest standards of quality, consistency, and operational excellence.

MILESTONES IN AUTOIMMUNITY

In 2024, CAR-T cell therapy demonstrated groundbreaking potential in treating autoimmune disease with significant clinical improvement and sustained remission.

Müller et al., 2024 | PMID: 38381673

Want to know more?

Have questions or need assistance? Our team is ready to help. Discover how AROTEC’s solutions and expertise can meet your business demands.